Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

ARCTARCT
Showing 7 of 19 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in ARCTURUS THERAPEUTICS HLDGS

Point72 Asset Management, L.P. holds 231,582 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $1.6M as of 2026-Q2. The position was increased (+262.7% shares). ARCT represents 0.0% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$1.6M

Current Shares

231,582

Total Value Change

+$1.6M

Total Shares Change

+231,582

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
231,582
+262.7%
$1.6M0.0%$6.72
41
2026-Q1
Decreased
63,845
-71.3%
$492,8830.0%$7.91
0
2025-Q4
New
222,163
-
$1.4M0.0%$6.19
35
2025-Q3
Exited
0
-100.0%
$00.0%$18.78
0
2025-Q2
Decreased
6,154
-40.4%
$80,0590.0%$13.33
0
2025-Q1
New
10,317
-
$109,2570.0%$11.58
30
2024-Q3
Exited
0
-100.0%
$00.0%$22.03
0

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used